Kala Pharmaceuticals to present preclinical data on mucosal-penetrating particle technology

Download PDF Copy

Editorial Checklist

Reviewed

Kala PharmaceuticalsJul 20 2013

NewsGuard 100/100 Score

Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Kala researchers will present preclinical data at the upcoming Controlled Release Society (CRS) 2013 Annual Meeting taking place July 21-24, 2013, in Honolulu, HI. The poster presentation will highlight the capability of Kala's proprietary Mucosal-Penetrating Particle (MPP) technology to enhance topical drug delivery to the front and back of the eye.

“Mucosal-Penetrating Particles Enable Topical Delivery to Posterior Segment of the Eye”

Poster Presentation:

(Abstract #100749, Poster #696): Monday, July 22, 2013, 9:30-10:30am HST, "Mucosal-Penetrating Particles Enable Topical Delivery to Posterior Segment of the Eye" Elizabeth Enlow, Kala Pharmaceuticals, Poster Session #1, Hawaii Convention Center.

Source:

Kala Pharmaceuticals

Posted in: Device / Technology News | Pharmaceutical News

Tags: Drug Delivery, Eye, Nanomedicine, Pharmaceuticals, Preclinical, Respiratory, Technology

Comments (0)

Download PDF Copy

Suggested Reading

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Predicting mood episodes with sleep data: A breakthrough for mental health care

Predicting mood episodes with sleep data: A breakthrough for mental health care

Online group programs aid weight loss but face hurdles

Online group programs aid weight loss but face hurdles

Obesity crisis in the U.S. expected to worsen by 2050

Obesity crisis in the U.S. expected to worsen by 2050

GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder

GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder

Utilizing process Raman in optimizing cultivated meat production

Utilizing process Raman in optimizing cultivated meat production

Study focuses on COPD progression in younger populations

Study focuses on COPD progression in younger populations

GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

GLP-1 receptor agonists prove effective for kidney and cardiovascular outcomes

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Small brain-penetrating molecule offers hope for treating aggressive brain tumors